The final two-year follows from th...
The final two-year follows from the Independent Comparison of Interferon studious mood (Schering AG, Berlin, Germany) were published 27 April 2002 in The Lancet. The outcomes show that Betaferon/Betaseron (interferon beta-1b) reduc signs of disease activity more effectively than Avonex (interferon beta-1a), particularly in the other year of treatment. In the inquiry 188 subjects with ...
|